AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,069 | 33,099 | 46,065 | 65,395 | 62,630 |
| Marketable Securities | 51,874 | 95,359 | 99,370 | 94,240 | 125,616 |
| Receivables | 646 | 411 | 4,307 | 347 | 288 |
| Other current assets | 236 | 428 | 52 | 448 | 165 |
| TOTAL | $120,701 | $134,230 | $152,783 | $164,018 | $191,736 |
| Non-Current Assets | |||||
| PPE Net | 4,335 | 4,463 | 4,852 | 5,175 | 5,315 |
| Investments And Advances | 390 | 378 | 374 | 374 | 393 |
| Intangibles | 54,485 | 52,831 | 52,186 | 52,211 | 54,596 |
| Other Non-Current Assets | 2,890 | 2,943 | 2,578 | 2,726 | 3,004 |
| TOTAL | $62,099 | $60,615 | $59,989 | $60,485 | $63,307 |
| Total Assets | $182,800 | $194,844 | $212,772 | $224,504 | $255,044 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,228 | 974 | 1,572 | 349 | 543 |
| Accrued Expenses | 9,351 | 9,868 | 11,361 | 10,962 | 11,447 |
| TOTAL | $11,623 | $12,031 | $14,077 | $12,349 | $12,898 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 449 | 615 | 542 | 440 | 288 |
| Other Non-Current Liabilities | 5,901 | 5,728 | 1,970 | 0 | 10,263 |
| TOTAL | $5,901 | $5,728 | $1,970 | $2,123 | $10,263 |
| Total Liabilities | $17,524 | $17,759 | $16,047 | $14,472 | $23,161 |
| Shareholders' Equity | |||||
| Common Shares | 1,942 | 1,883 | 1,860 | 1,860 | 1,944 |
| Retained earnings | -302,710 | -276,661 | -251,523 | -238,363 | -236,931 |
| Other shareholders' equity | -132 | -120 | -54 | -78 | -134 |
| TOTAL | $165,277 | $177,086 | $196,725 | $210,032 | $231,883 |
| Total Liabilities And Equity | $182,801 | $194,845 | $212,772 | $224,504 | $255,044 |